Abstracts

Outcomes of geriatric population with resectable colorectal liver metastases cancer: Data from real life

Background In selected patients with metastatic colorectal cancer (mCRC), resection of liver metastasis (LM) is the only potential curative option. The geriatric populat...

06/27/2022

Concordance between RAS and BRAF mutational status determination in ctDNA and tissue in patients with mCRC

Background Liquid biopsy is a tool that enables identification of diagnostic, prognostic and predictive biomarkers of response to treatment in circulating tumour DNA (ct...

Hernández J. Cruz ;

Brage E. Terán ;

Tocino R. Vidal ;

Francoso A. Rodrígues ;

López B. Rivas ;

Gutiérrez A. López ;

Pérez L. Figuero ;

Ampuero J. Claros ;

García B. Cigarral ;

Sánchez E. Fonseca ;

06/27/2022

Association between primary tumor site of colorectal cancer and RAS/BRAF mutational status with venous thromboembolism: A retrospective-prospective cohort study from 3 Croatian oncology centers

Background Right-sided colorectal cancer (RCRC) is associated with several negative clinicopathological and molecular features and also with worse survival than left-sid...

06/27/2022

Correlation between extramural vascular invasion (EMVI) and systemic inflammatory response markers in rectal cancer

Background Colorectal cancer (CRC) is the leading cause of cancer-related death worldwide. Rectal cancer constitutes around one-third of all CRCs. The current standard o...

L. Wyrwicz ;

Cieszymierz Gawiński ;

Anna Hołdakowska ;

06/27/2022

Impact of local treatments on survival of patients with liver metastases from colorectal cancer (CRC) in real-life setting

Background Liver is the most common site of metastases from CRC. Up to 70% of CRC patients develop liver metastases in their course of disease. Surgical resection is the...

06/27/2022

Fluoropyrimidine- and irinotecan-induced toxicity profile associated with mutations in DPYD and UGT1A1 genes

Background Fluoropyrimidines are a mainstay in the treatment of gastrointestinal tumours (GIT), although they can sometimes produce severe toxicity, usually related to p...

Brage E. Terán ;

Tocino R. Vidal ;

García B. Cigarral ;

Sánchez E. Fonseca ;

Martín M. Navarro ;

Jung D. Heredero ;

Berrocal B. García ;

Jiménez M. Navalón ;

06/27/2022

A scoring model to predict the clinical outcome of self-expandable metal stents in patients with colorectal obstruction due to extracolonic malignancy

Background Self-expandable metal stents (SEMS) can be applied to relieve colorectal obstruction secondary to extracolonic malignancy (ECM), but data regarding this issue...

06/27/2022

Management of insulinoma, changing trends in developing world

Background Insulinoma is uncommon endocrine tumors that have a prevalence of around 1 per 100,000 person-years. However; they represent the most common functioning endoc...

06/27/2022

Oxaliplatin desensitization in coloretal cancer: A way to prolong effective treatments

Background Hypersensitivity reactions (HSR) to oxaliplatin can lead to the suspension of potentially effective treatments. An alternative approach, such as the use of de...

06/27/2022

Mutational testing on liquid biopsies for treatment decisions in metastatic colorectal cancer – comparison of ddPCR and MassARRAY methods

Background The aim was to investigate if mutational analysis of circulating DNA (cfDNA) in plasma is feasible for selection of patients with metastatic colorectal cancer...

06/27/2022